Latest Gross Margins News

DataDot Technology Limited (ASX:DDT) delivered a stronger FY26, with revenue rising 14.1% to $3.85 million and profit before tax nearly tripling to $327,420. The sharper result was driven largely by PropertyVAULT’s first full year of insurance services, although key insurer relationships remain pilots or works in progress.

Canadian Phosphate has completed 18 Wapiti drill holes and visually traced its phosphate Main Zone across approximately 9km, although laboratory assays are still pending. The company has also completed its Utah acquisition, reported stronger rock phosphate orders and ended September with $3.144 million in cash.

Saluda Medical delivered 28% FY26 revenue growth and expanded its spinal cord stimulation opportunity with CAP24, but its annual report warns that additional capital may be needed within 12 months. The ASX-listed medical device company also begins FY27 under new CEO Michael Mathias.

IPD Group closed FY26 with record revenue and earnings, a higher fully franked dividend and leverage of about 0.3 times underlying EBITDA. The electrical infrastructure provider enters FY27 with its data centre pipeline and Platinum Cables integration carrying much of the growth narrative.

Lovisa delivered another year of strong reported growth, with revenue rising 17.6% to A$938.8 million as its store network passed 1,100 locations. But comparable store sales grew just 2.0%, leaving management’s expansion engine carrying more of the load while executive incentive hurdles went unmet.

IKE has lowered its previously indicated FY27 subscription revenue growth expectation of about 35%, citing contract timing rather than weaker demand or churn. The NZX and ASX-listed software company still expects its subscription exit run rate to grow by more than 30% by March 2027, while three new products remain on track for launch.

Jatcorp’s revenue rose 23% to $38.9 million in FY2026, but weaker margins, negative operating cash flow and a material going-concern uncertainty leave the nutritional products maker’s recovery unfinished. The company ended the year with $5.6 million in cash after a $4.2 million entitlement offer, while Neurio trademark litigation in China remains unresolved.

Michael Hill has started FY27 with same-store sales growth across all three markets, led by an 11.3% rise in Canada. The jewellery retailer says gross margin remains stable and expects profitable growth, but Christmas trading will determine how much of the momentum reaches earnings.

Recce Pharmaceuticals has granted Arrotex exclusive rights to commercialise its investigational RECCE 327 topical gel in Australia and New Zealand. The agreement offers a potential profit-share stream, but no upfront payments, sales forecast or approval have been disclosed.

Bapcor says its operational reset is beginning to show through, with first-quarter Trade sales up 2.5%, margins improving and net debt falling to $116 million. The recovery remains early, however, with Retail still under pressure and FY27 earnings weighted heavily to the second half.

Laserbond delivered strong FY26 growth despite higher tungsten costs and soft mining demand, while securing a second Komatsu licensing agreement and a new international collaboration with Metal 7. The company is now positioning lower-tungsten products, new coatings and expanded capacity for a much larger market.

Harris Technology has started FY27 with $4.3 million in quarterly revenue, positive operating cash flow and a sharp reduction in borrowings. Refurbished technology accounted for about 60% of sales, although parts delays constrained August and September activity.